Chemoinformaics analysis of DIISOAMYL DISULFIDE
| Molecular Weight | 206.42 | nRot | 7 |
| Heavy Atom Molecular Weight | 184.244 | nRig | 0 |
| Exact Molecular Weight | 206.116 | nRing | 0 |
| Solubility: LogS | -5.661 | nHRing | 0 |
| Solubility: LogP | 4.715 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 37.1694 |
| nHD | 0 | BPOL | 24.5306 |
| QED | 0.445 |
| Synth | 2.678 |
| Natural Product Likeliness | 0.149 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.284 |
| MDCK | 0.0000243 |
| BBB | 0.775 |
| PPB | 0.960453 |
| VDSS | 1.527 |
| FU | 0.0353524 |
| CYP1A2-inh | 0.708 |
| CYP1A2-sub | 0.687 |
| CYP2c19-inh | 0.634 |
| CYP2c19-sub | 0.919 |
| CYP2c9-inh | 0.654 |
| CYP2c9-sub | 0.94 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.207 |
| CYP3a4-inh | 0.038 |
| CYP3a4-sub | 0.215 |
| CL | 13.12 |
| T12 | 0.124 |
| hERG | 0.02 |
| Ames | 0.042 |
| ROA | 0.024 |
| SkinSen | 0.912 |
| Carcinogencity | 0.349 |
| EI | 0.993 |
| Respiratory | 0.167 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.834033 |